Hot Pursuit     18-Feb-25
KIMS Hospitals joins hands with UAIMS Hospital to expand biz into Sangli
Krishna Institute of Medical Sciences (KIMS) said that it has entered into strategic partnership with Ushahkal Abhinav Institute of Medical Sciences (UAIMS Hospital), Sangli, Maharashtra to strengthen its presence in Maharashtra.
UAIMS Hospital, started in 2022, is one of the most advanced quaternary care hospitals in the Sangli region in Maharashtra. The hospital currently has installed capacity of 356 beds and has potential to expand to 500+ beds. It has latest medical infrastructure including CT, MRI & 15 state-of-the-art operation theatres and a dedicated mother & child care facility spread across an entire floor. It has also announced launch of a comprehensive day care oncology center adjacent to the hospital. This facility is currently under construction and is expected to be operationalised in 2025.

The company has taken over the operations and management of UAIMS Hospital, located in Sangli, Maharashtra. This partnership will also enable KIMS to exercise call option (not an obligation) to acquire majority stake in UAIMS Hospital in the coming years. The new entity will be known as KIMS-UAIMS Hospital.

KIMS has already announced 300 bed multi-specialty hospital in Thane slated to commence operations in the first quarter of next financial year.

Commenting on its foray into Sangli, Dr Bhaskar Rao, CMD, KIMS Hospitals, said, “Maharashtra is an important market for us. Our foray into Sangli signifies our commitment to bring our trusted affordable, advanced and accessible healthcare model to more geographies of Maharashtra. We will continue to look for a mix of greenfield and brownfield strategy for ramping up our presence in Maharashtra.”

Headquartered in Hyderabad, Krishna Institute of Medical Sciences (KIMS Hospitals) is one of the largest corporate healthcare groups in Telangana, Andhra Pradesh and Mahrashtra, providing multi-disciplinary integrated healthcare services, with a focus on tertiary and quaternary healthcare at affordable cost.

The company’s consolidated net profit jumped 23.5% to Rs 88.70 crore in Q3 FY25 as compared with Rs 71.84 crore in Q3 FY24. Net sales increased 27.5% YoY to Rs 772.40 crore in Q3 FY25.

The scrip shed 0.22% to Rs 557.45 on the BSE.

Previous News
  Krishna Institute of Medical Sciences consolidated net profit declines 9.24% in the June 2025 quarter
 ( Results - Announcements 06-Aug-25   15:52 )
  KIMS Hospitals board grants nod to 1:5 stock split proposal
 ( Hot Pursuit - 28-Jun-24   11:54 )
  Krishna Institute of Medical Sciences to invest Rs 1.02 cr in Meda Institute of Podiatry
 ( Corporate News - 11-Jun-24   16:46 )
  KIMS Hospitals’ rises as Q1 PAT climbs 7% YoY; ARPOB at Rs 38,458
 ( Hot Pursuit - 08-Aug-24   13:24 )
  Krishna Institute of Medical Sciences Ltd Slides 7.65%
 ( Hot Pursuit - 03-Mar-25   09:30 )
  Krishna Institute of Medical Sciences consolidated net profit declines 6.41% in the December 2022 quarter
 ( Results - Announcements 10-Feb-23   07:38 )
  Krishna Institute of Medical Sci. to hold AGM
 ( Corporate News - 18-May-24   17:37 )
  Krishna Institute of Medical Sci. to convene board meeting
 ( Corporate News - 25-Jul-24   15:01 )
  Krishna Institute of Medical Sci. to announce Quarterly Result
 ( Corporate News - 02-May-24   15:45 )
  Krishna Institute of Medical Sci. to conduct board meeting
 ( Corporate News - 12-May-23   10:32 )
  Volumes jump at 360 ONE WAM Ltd counter
 ( Hot Pursuit - 05-Jan-24   11:00 )
Other Stories
  LIC ends higher after Q2 PAT climbs 32% YoY to Rs 10,053 cr
  07-Nov-25   17:06
  Lupin Q2 PAT climbs 73% YoY to Rs 1,478 crore in FY26
  07-Nov-25   16:08
  Akzo Nobel gains after reporting multi-fold Q2 PAT
  07-Nov-25   15:09
  Interarch Building hits record high after reporting strong Q2 performance
  07-Nov-25   15:05
  Amber Enterprises India Ltd leads losers in 'A' group
  07-Nov-25   15:00
  Artificial Electronics Intelligent Material hits the roof after multi-fold Q2 profit surge
  07-Nov-25   14:51
  Bliss GVS Pharma Ltd leads losers in 'B' group
  07-Nov-25   14:45
  Volumes spurt at Aarti Industries Ltd counter
  07-Nov-25   14:30
  Lumax Industries slides after Q2 PAT slips 2% QoQ to Rs 36 cr
  07-Nov-25   14:25
  Alembic Pharma gets USFDA final approval for Dasatinib tablets in multiple strengths
  07-Nov-25   13:44
Back Top